Clinical trial

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and…

NCT00349076 · University of Erlangen-Nürnberg Medical School, Other · Completed

Key facts

NCT number NCT00349076
Title Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
Official title Prospective Randomised Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil for Locally Advanced Rectal Cancer
Lead sponsor University of Erlangen-Nürnberg Medical School, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Rectal Neoplasms
Intervention type Drug
Interventions 5-FU and oxaliplatin, 5-FU
Enrollment 1,256
Start date Jul 1, 2006
Primary completion Dec 1, 2015
Completion Jun 1, 2016
First posted Jul 6, 2006
Last update posted Aug 1, 2016
Countries Germany

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies